Since graduating from The EpiCentre in March 2022, Amphista has established itself at Granta Park, Cambridge, a world-leading hub for biopharmaceutical innovation. Amphista’s mission is to unlock the full potential of Targeted Protein Degradation (TPD) by developing a new generation of transformational medicines using their proprietary Targeted Glue® technology.
MultiplAI Health is redefining the future of healthcare with their ground-breaking RNA-based, AI-driven screening technology. After graduating from The EpiCentre in July 2023, MultiplAI Health has continued to accelerate innovation in early disease detection, developing a simple blood test that transforms how cardiovascular and complex diseases are diagnosed.
K9 Digital stands out as a creative powerhouse within The EpiCentre’s vibrant community. Founded by industry veterans with a passion for character creation, K9 Digital specialises in 3D character, creature, and animal art for games, VR, TV, and film.
PES Technologies embodies the pioneering spirit at the heart of The EpiCentre community. After graduating from the centre in May 2025, PES Technologies has continued to make waves in the agri-tech sector, driven by their mission to revolutionise soil health measurement.
Analog Devices continues to set the pace for innovation in the semiconductor industry, demonstrating the transformative impact of The EpiCentre’s collaborative environment. In October 2023, Analog Devices launched ADI Power Studio, a comprehensive suite of products designed to empower engineers with advanced modelling, intelligent component recommendations, and efficiency analysis through simulation.
After graduating from The EpiCentre in March 2024, ExpressionEdits was invited to join the prestigious Babraham Institute, marking a significant milestone in their journey. Just two months later, the team secured an impressive $13M in seed funding, fuelling their mission to advance protein expression through pioneering AI-driven intronization technology
Join an inspiring community of innovators and entrepreneurs.
Stay in touch with what’s happening at The EpiCentre. Pop in your details below and confirm you’re happy for us to send you emails, and we’ll keep you up to date with all that’s happening at The EpiCentre.
Disclaimer: The EpiCentre uses the information you provide on this form to get in touch with you and provide updates and for marketing purposes. You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us. We treat all personal information with respect. By subscribing, you agree that we may process your information in accordance with these terms.
Space to experiment, space to research
Space to experiment, space to research
Update – 11 August 2022
Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.
